Vitex-2 Compact Identification of Candida Species Isolated from Urine Samples of Diabetic Patients in Rural Indonesian Community
DOI:
https://doi.org/10.30595/pshms.v6i.1425Keywords:
Diabetes Mellitus, Fungal Infection, Candida Spp., Urine, Vitek-2 CompactAbstract
Diabetes mellitus (DM) increases the risk of fungal infections, particularly in the urine. The genus Candida is the most common cause of fungal infections in immunocompromised patients, including those with DM. The use of automatic identification tools such as Vitek-2 Compact allows for the rapid and accurate identification of Candida species. This study aims to identify the types of pathogenic fungi present in the urine of DM patients. This descriptive study used a cross-sectional design. Fungal examination were conducted macroscopically and microscopically on 15 urine samples from DM patients cultured on Sabouraud Dextrose Agar (SDA) media. Further identification was performed using the Vitek-2 Compact system to determine the species of fungi in positive samples. Culture results releaved that 12 out of 15 urine samples (80%) showed positive fungal growth. Identification using the Vitek-2 Compact system indicated a dominance of Candida species (66,7%), with Candida guilliermondii (33,3%) being the most frequently found species. Other fungal species identified included Candida krusei (16,7%), Candida famata (16,7%), Trichosporon asahii (16,7%), and Kodamaea ohmeri (16,7%). This study found a high prevalence of Candida infections in the urine of diabetic patients, with Candida guilliermondii being the most frequently identified species. The use of the Vitek-2 Compact system proved to be an effective method for the rapid and accurate identification of fungal species, highlighting its importance in clinical diagnostics. These findings emphasize the need for routine fungal screening in diabetic patients, as well as the importance of early and targeted antifungal therapy to prevent the complications associated with fungal infections, particularly in rural settings where healthcare resources may be limited.
References
World Health Organization, “The Top 10 Causes of Death,” World Health Organization, 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
H. Nouraei, M. G. Jahromi, L. R. Jahromi, K. Zomorodian, and K. Pakshir, “Potential Pathogenicity of Candida Species Isolated from Oral Cavity of Patients with Diabetes Mellitus,” Biomed Res. Int., vol. 2021, no. type 1, pp. 1–6, 2021.
B. Saud, P. Bajgain, G. Paudel, V. Shrestha, D. Bajracharya, S. Adhikari, G. Dhungana, and M. S. Awasthi, “Fungal Infection among Diabetic and Nondiabetic Individuals in Nepal,” Interdiscip. Perspect. Infect. Dis., pp. 1–7, 2020, doi: 10.1155/2020/7949868.
V. Patricia, A. Yani, and N. P. Haifa, “Gambaran Candida Albicans Pada Urin Penderita Diabetes Mellitus di Puskesmas Neglasari,” J. Med. Lab. Sci., vol. 2, no. 1, pp. 16–22, 2022, doi: 10.36086/medlabscience.v2i1.1274.
A. Y. Anwar and F. Jakaria, “Pola Pertumbuhan Jamur Candida Spp. pada Urine Penderita Diabetes Melitus dengan Glukosa Terkontrol dan Tidak Terkontrol: Penelitian Laboratorium,” Heal. Inf. J. Penelit., vol. 15, no. 3, 2023, doi: 10.36990/hijp.v15i3.1134.
O. J. Akinjogunla, O. M. Divine-Anthony, A. O. Ajayi, I. U. Etukudo, and I. J. Etok, “Asymptomatic Candiduria Among Type 1 and 2 Diabetes Mellitus Patients: Risk and Sociodemographic Factors, Prevalence, Virulence Markers and Antifungal Susceptibility,” J. Pure Appl. Microbiol., vol. 14, no. 2, pp. 1467–1478, 2020, doi: 10.22207/JPAM.14.2.44.
N. R. Yun, “Fungal Infection in Patients with Diabetes Mellitus,” J. Korean Diabetes, vol. 18, no. 1, p. 20, 2017, doi: 10.4093/jkd.2017.18.1.20.
Y. Suryani, O. Taupiqurrahman, and Y. Kulsum, MIKOLOGI, 1st ed. Padang, Sumatera Barat: PT. Freeline Cipta Granesia, 2020. [Online]. Available: https://etheses.uinsgd.ac.id/31111/13/BUKU MIKOLOGI Dr. Yani Suryani_Lengkap.pdf
D. M. Atef and R. A. Ghonaim, “The Role of Vitek-2 Automated System in Identification and Susceptibility Testing of Gram Negative Rods in an Intensive Care Unit Patients in Egypt,” Cairo Univ, vol. 82, no. 1, pp. 357–362, 2014, [Online]. Available: www.medicaljournalofcairouniversity.net
A. Purwitaningsih and A. K. Setya, “Pemeriksaan Jamur Candida albicans pada Urine Penderita Diabetes Melitus di Rumah Sakit Umum Islam Klaten,” J. Ilm. Anal. Kesehat., vol. 9, no. 1, pp. 33–41, 2023.
C. H. P. A T Jamiu, J Albertyn, O M Sebolai, “Update on Candida krusei, a potential multidrug-resistant pathogen,” Med. Mycol., vol. 59, no. 1, pp. 14–30, 2021, [Online]. Available: https://doi.org/10.1093/mmy/myaa031
M. Gómez-Gaviria and H. M. Mora-Montes, “Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen,” Infect. Drug Resist., vol. 13, pp. 1673–1689, 2020.
S. Kumar, A. Kumar, M. Roudbary, R. Mohammadi, L. ?ernáková, and C. F. Rodrigues, “Overview on the Infections Related to Rare Candida Species,” Pathogens, vol. 11, no. 9, pp. 1–45, 2022, doi: 10.3390/pathogens11090963.
H. Li, M. Guo, C. Wang, Y. Li, A. M. Fernandez, T. N. Ferraro, R. Yang, and Y. Chen, “Epidemiological Study of Trichosporon Asahii Infections Over the Past 23 Years,” Epidemiol. Infect., pp. 1–8, 2020, doi: 10.1017/S0950268820001624.
M. Zhou, Y. Li, T. Kudinha, Y. Xu, and Z. Liu, “Kodamaea ohmeri as an Emerging Human Pathogen: A Review and Update,” Front. Microbiol., vol. 12, no. September, pp. 1–9, 2021, doi: 10.3389/fmicb.2021.736582.
P. Rachapromma, C. Chayachinda, C. Kerdklinhom, and W. Iamvijarn, “Nursing Care for Women with Acute Vaginal Candidiasis,” Siriraj Med. Bull., vol. 15, no. 2, pp. 107–113, 2022.
S. Indrayati, Suraini, and M. Afriani, “Gambaran Jamur Candida sp. dalam Urine Penderita Diabetes Mellitus di RSUD dr. Rasidin Padang,” J. Kesehat. Perintis, vol. 5, no. 1, pp. 1–7, 2018.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Proceedings Series on Health & Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
